Skip to main content

Table 1 Association of laboratory data and LDH, NOm and HDL-C levels in SCA patients

From: Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia

 

LDH <1094.0 U/L (N = 29)

LDH ≥1094.0 U/L (N = 70)

Nitric Oxide m <35.75 μM (N = 59)

Nitric Oxide m ≥35.75 μM (N = 38)

HDL-C <40.00 mg/dL (N = 81)

HDL-C ≥40.00 mg/dL (N = 18)

P1

P2

P3

 

Median (25th -75th)

Median (25th -75th)

Median (25th -75th)

Median (25th -75th)

Median (25th -75th)

Median (25th -75th)

p-value

Hemolysis

 RBC, x1012/L

2.7 (2.4–3.1)

2.5 (2.2–2.7)

2.6 (2.3–2.8)

2.4 (2.2–2.8)

2.5 (2.2–2.8)

2.7 (2.4–3.1)

0.015*

0.176*

0.018

 Hemoglobin, g/dL

7.9 (7.3 –9.1)

7.5 (7.0–8.5)

7.6 (7.20–8.5)

7.5 (6.6–8.5)

7.6 (7.1–8.5)

7.9 (7.1–10.0)

0.040*

0.349

0.049

 Hematocrit, %

23.1 (21.3–26.7)

21.5 (19.8–24.0)

21.7 (20.20–25.5)

21.8 (18.9–24.1)

21.7 (20.0–24.1)

22.9 (20.8–27.7)

0.016*

0.346

0.036

 MCV, fL

83.8 (78.8–88.1)

88.1 (83.5–92.8)

85.1 (81.20–89.8)

88.2 (83.0–94.6)

86.4 (81.6–91.3)

85.0 (80.9–90.5)

0.030

0.120

0.403

 MCH, fL

29.1 (26.5–31.3)

30.5 (28.7–32.6)

29.9 (27.80–32.1)

30.7 (27.8–32.7)

30.4 (28.0–32.7)

29.6 (27.7–31.3)

0.032

0.260

0.288

 Total bilirubin, mg/dL

1.9 (1.3–3.4)

3.1 (1.8–3.9)

2.3 (1.60 –3.8)

3.2 (1.8–3.9)

2.8 (1.8–3.8)

2.0 (0.5–3.8)

0.028

0.183

0.983*

 Direct bilirubin, mg/dL

0.4 (0.3–0.5)

0.5 (0.3–0.6)

0.4 (0.30–0.5)

0.5 (0.4–0.7)

0.5 (0.3–0.6)

0.4 (0.2–0.6)

0.166

0.024

0.501

 Indirect bilirubin, mg/dL

1.5 (0.9–2.6)

2.4 (1.4–3.3)

2.0 (1.20–3.3)

2.4 (1.4–3.3)

2.2 (1.3–3.2)

1.4 (0.4–3.2)

0.025

0.085*

0.958*

 LDH, U/L

  

1096.0 (837.0–1713.5)

1201.0 (830.0–1931.2)

1096.0 (837.0 –1713.5)

937.5 (650.0–1546.7)

 

0.152*

0.416*

 Reticulocyte count

5.9 (3.9–8.2)

5.25 (4.40–8.12)

5.0 (3.9–7.1)

7.1 (4.9–8.6)

5.3 (4.2–7.9)

5.9 (4.0–10.7)

0.775*

0.012

0.498*

Hemoglobin profile

 Fetal hemoglobin, %

11.4 (4.6–17.4)

8.7 (5.2–13.0)

9.6 (5.3–14.8)

8.9 (3.8–13.0)

7.9 (4.2–13.1)

13.4 (8.7–19.0)

0.077*

0.311*

0.005

NO metabolites

 NOm, μM

34.6 (29.1–42.8)

36.1 (27.9–51.0)

  

37.6 (29.1–51.1)

30.5 (26.3–36.8)

0.702

 

0.024

Leukocytes

 WBC, x 109/L

14.3 (11.5–16.6)

13.7 (11.1–15.8)

13.7 (11.1–16.0)

13.90 (11.7–16.6)

13.9 (11.4–15.9)

12.2 (10.4–16.9)

0.508

0.450

0.751*

 Neutrophil, x 109/L

6664.0 (4209.0–8355.0)

5382.0 (4080.0–7113.5)

5424.0 (3892.0–7182.0)

6088.0 (4485.2–7203.5)

5760.0 (4210.5–71.82.0)

5516.0 (3361.5–7691.0)

0.305

0.387

0.824

 Eosinophil, x 109/L

714.0 (255.5–1967.0)

685.0 (288.7–1608.7)

800.0 (291.0–1807.0)

704.5 (281.5–2109.0)

805.0 (303.5–1925.0)

502.0 (238.5–1328.2)

0.319*

0.336*

0.415*

 Lymphocyte, x 109/L

5408.0 (4540.0–6726.5)

5580.0 (4261.0–7564.5)

5408.0 (3990.0–7224.0)

5939.5 (4491.5–7569.7)

5560.0 (4359.0–7209.5)

5798.0 (3751.5–7728.0)

0.508

0.439*

0.647

 Monocyte, x 109/L

290.0 (169.0–419.0)

454.5 (248.5–763.2)

338.0 (222.0–576.0)

377.5 (212.5–863.0)

330.0 (212.0–680.5)

492.0 (309.0–720.7)

0.017*

0.296*

0.792

Platelets

 Platelet, x103/mL

450.0 (350.0–514.0)

439.0 (367.7–550.2)

445.0 (384.0–558.0)

419.5 (342.5–514.5)

442.0 (358.0–559.0)

439.5 (402.0–497.0)

0.982

0.337

0.345

Lipid profile

 Total Cholesterol, mg/dL

132.0 (85.0–152.0)

120.5 (101.5–144.5)

131.0 (111.0–153.0)

109.0 (85.5–146.0)

  

0.933

0.014*

 

 HDL-C, mg/dL

33.0 (28.5–40.5)

31.0 (26.0–36.2)

34.0 (28.0–40.0)

30.0 (26.0–33.2)

  

0.108

0.018

 

 LDL-C, mg/dL

66.0 (41.5–87.5)

67.0 (44.0–88.2)

74.0 (57.0–99.0)

51.5 (30.5–84.2)

66.0 (40.0–84.0)

92.0 (73.5–128.2)

0.982

0.007*

<0.001

 VLDL-C, mg/dL

22.0 (16.0–33.0)

22.0 (17.0–31.0)

21.0 (16.0–26.0)

28.0 (18.0–35.0)

23.0 (17.0–32.0)

20.0 (15.5–28.5)

0.948

0.003*

0.036

 Triglycerides, mg/dL

109.0 (81.0–164.0)

110.0 (84.0–155.2)

103.0 (78.0–130.0)

139.0 (91.7–176.5)

113.0 (83.5–158.5)

101.5 (78.7–144.0)

0.951

0.008*

0.441

  1. RBC red blood cell, MCV mean cell volume, MCH: mean corpuscular hemoglobin, LDH dehydrogenase, NOm, nitric oxide metabolites, WBC white blood cell, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, VLDL-C very low-density lipoprotein cholesterol. Bold values indicate significance at p < 0.05; p-value obtained using Mann-Whitney test. *p-value obtained using t-test. P1 = LDH <1094.0 U/L X LDH ≥ 1094.0 U/L; P2 = NOm < 35.75 μM X NOm ≥ 35.75 μM; P3 = HDL-C < 40.0 mg/dl x HDL-C ≥40.0 mg/dL